VR8
0.059
55.3%
KYN
0.03
-21.1%
BEO
0.12
50%
G11
0.2
-20%
IMM
0.056
27.3%
MQR
0.004
-20%
CMO
0.005
25%
ALB
0.049
-18.3%
EXT
0.005
25%
AM5
0.005
-16.7%
FZR
0.4
23.1%
CTQ
0.015
-16.7%
CRB
0.012
20%
MGU
0.005
-16.7%
LIO
0.012
20%
W2V
0.042
-16%
PKO
0.012
20%
PAR
0.24
-15.8%
1MC
0.033
17.9%
RVT
0.11
-15.4%
TZL
0.033
17.9%
SVG
0.006
-14.3%
EM2
0.007
16.7%
LEX
0.125
-13.8%
FEL
0.007
16.7%
RML
0.052
-13.3%
CTD
2.46
15.5%
CAZ
0.02
-13%
A8G
0.2
14.3%
FCT
0.007
-12.5%
CXU
0.12
14.3%
GT1
0.014
-12.5%
M96
0.008
14.3%
LIT
0.007
-12.5%
PCL
0.008
14.3%
OEL
0.007
-12.5%
YUG
0.049
14%
PLC
0.007
-12.5%
BPM
0.25
13.6%
ZEU
0.007
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

The latest ASX articles

EBR Systems (ASX:EBR): How the WiSE® Coupler was developed to support implantation

Transcription of The Stock Network Interview with EBR Systems (ASX:EBR), Senior Director of Research &...

Metals Australia (ASX:MLS): Arrowhead research highlights share fair value and growth opportunities

Transcription of The Stock Network Interview with Metals Australia (ASX:MLS), CEO Paul Ferguson Lel Smits: A...

GoldArc Resources (ASX:GA8): Building a bigger Leonora gold hub as drilling accelerates

Transcription of The Stock Network Interview with GoldArc Resources (ASX:GA8), Managing Director Paul Stephen Lel Smits:...

EBR Systems (ASX:EBR) advances life-saving cardiac resynchronisation into the wireless age

WiSE CRT is the first leadless CRT system to win FDA pre-market approval. 117 US...

Acrux (ASX:ACR) pushes Female Testosterone MDTSMDTS toward Phase III on stated FDA feedback

Acrux says FDA feedback confirms its Phase I and II data give it a clear...

Argo Investments (ASX:ARG): Finding income and the human edge in the age of AI

Transcription of The Stock Network Interview with Argo Investments (ASX:ARG), Managing Director Jason Beddow Lel...

Myopharm: Advancing TriGlytza® as a new treatment for Type 2 diabetes

Transcription of The Stock Network Interview with Myopharm, CEO and Executive Chair Karinza Phoenix Lel Smits:...

Change Financial (ASX:CCA): Record results mark maiden full year profit

Transcription of The Stock Network Interview with Change Financial (ASX:CCA), CEO Tony Sheehan Lel Smits: Change...

Imagion Biosystems (ASX:IBX): How MagSense® is moving towards Phase 2 clinical trials

Transcription of The Stock Network Interview with Imagion Biosystems (ASX:IBX), Chair Bob Proulx Lel Smits: Imagium...

Pengana Global Private Credit Trust (ASX:PCX): Private credit is booming, how you access it matters

Transcription of The Stock Network Interview with Pengana Global Private Credit Trust (ASX:PCX), CEO Nehemiah...

Maritana Minerals (ASX:MRT): Gold reserves surge 148% as WA growth accelerates

Transcription of The Stock Network Interview with Maritana Minerals (ASX:MRT), Managing Director and CEO Grant...

Michael Hill International (ASX/NZX:MHJ): Turnaround delivers record results and renewed growth

Transcription of The Stock Network Interview with Michael Hill International (ASX/NZX:MHJ), CEO Jonathan Waecker Lel Smits:...

View More

Get the latest ASX stock market news delivered to your inbox

By proceeding, you can confirm you understand that we handle personal informational in accordance with our Privacy Policy